OnKure Therapeutics nabs $60M as HDAC inhibitor awaits solid-tumor readouts

Redirecting to:

The Newsroom

Subscribe to The Insider E-Newsletters

The Insider is Venture Partners at ²ÊÃñ±¦µä's monthly newsletter featuring the latest headlines, news, events, opportunities and emerging innovations from the university. We have several editions for our audiences:

 Subscribe to The Insider  

Media Inquiries

For marketing and communication inquiries or news tips, contact Daniel Leonard, senior marketing and communications specialist for Venture Partners at ²ÊÃñ±¦µä.

For media inquiries, please visit .

Latest News

Visit the Newsroom